Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Markku, Laakso"'
Autor:
Alena Stančáková, Tiina Kuulasmaa, Matti Jauhiainen, Markku Laakso, Mika Ala-Korpela, Raimo Jauhiainen, Johanna Kuusisto
Publikováno v:
European Heart Journal. 39
Autor:
Päivi Lepistö, Jianjun Wang, Sanna Ruotsalainen, Markku Laakso, Leena Moilanen, Johanna Kuusisto
Publikováno v:
European Heart Journal. 28:857-864
Aims The metabolic syndrome (MetS) is defined as a clustering of cardiovascular risk factors characterized by insulin resistance. We investigated the relationship of the MetS and its single components, defined by all six different criteria, with coro
Autor:
A Bootsma, K MacLeod, Karl-Johan Malmberg, Anders Hamsten, Anders Waldenström, Kåre I. Birkeland, S. Efendic, Per Hildebrandt, Hans Wedel, Johan Herlitz, Markku Laakso, Lars Rydén, Kenneth Dickstein, Miles Fisher, C Torp-Pedersen
Publikováno v:
European Heart Journal. 26:650-661
Patients with diabetes have an unfavourable prognosis after an acute myocardial infarction. In the first DIGAMI study, an insulin-based glucose management improved survival. In DIGAMI 2, three treatment strategies were compared: group 1, acute insuli
Autor:
Tapani Rönnemaa, S. M. Haffner, Kalevi Pyörälä, Heikki Miettinen, Seppo Lehto, Markku Laakso, Pekka Saikku
Publikováno v:
European Heart Journal. 17:682-688
Objective It has been suggested that Chlamydia pneumoniae , a Gram-negative intracellular bacterium, is a risk factor for both myocardial infarction and chronic coronary heart disease. Previous studies have been done predominantly in non-diabetic sub
Autor:
Timothy M. E. Davis, David C Burgess, Stewart Mann, David M. Hunt, Diana Zannino, Liping Li, Seppo Lehto, Elizabeth A. Williamson, Markku Laakso, Raymond W. Sy, Anthony C Keech, Jun Zhang, Y. Antero Kesäniemi
Publikováno v:
European heart journal. 31(1)
Aims To determine the incidence and predictors of, and effects of fenofibrate on silent myocardial infarction (MI) in a large contemporary cohort of patients with type 2 diabetes in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD)
Autor:
Raija Miettinen, Kari Ylitalo, Petri Tuomainen, Maija Kaartinen, Tiina Heliö, Keijo Peuhkurinen, Lauri Toivonen, Markku Laakso, Satu Kärkkäinen, Paula Peltola, Juha Rummukainen, Markku S. Nieminen, Johanna Kuusisto
Publikováno v:
European heart journal. 25(10)
Aims The mutations most frequently associated with dilated cardiomyopathy (DCM) have been reported in the lamin A/C gene. The role of variants of the lamin A/C gene was investigated in patients with DCM from eastern and southern Finland. Methods and
Publikováno v:
European heart journal. 2(4)
The case history of a patient is reported who had two episodes of unconsciousness while on anti-hypertensive therapy consisting of hydrochloroihiazide, hydralazine, and sotalol (480-640 mg as a single daily dose). Ventricular fibrillation which was s